v3.26.1
Equity Award Plans (Tables)
 9 Months Ended
Apr. 30, 2026
Share-Based Payment Arrangement [Abstract]  
Schedule of RSU and PSU Activities
The following table summarizes the RSU and PSU activity under our stock plans during the nine months ended April 30, 2026 (in millions, except per share amounts):
Unvested RSUs
Unvested PSUs
Number of Shares
Weighted-Average Grant-Date Fair Value Per Share
Aggregate Intrinsic Value
Number of Shares
Weighted-Average Grant-Date Fair Value Per Share
Aggregate Intrinsic Value
Balance—July 31, 202513 $143.33 $2,285 9 $140.92 $1,635 
Granted(1)(2)
14 $178.55 4 $186.49 
Vested(3)
(6)$140.04 (3)$150.47 
Forfeited(2)$153.49 (2)$142.73 
Balance—April 30, 202619 $169.21 $3,450 8 $156.51 $1,461 
(1)For PSUs, shares granted represent the aggregate maximum number of shares that may be earned and issued with respect to these awards over their full terms.
(2)Includes 7 million RSUs assumed in connection with the acquisitions of Chronosphere, CyberArk, and Koi, with weighted-average grant-date fair value of $176.20, $165.30, and $161.59 per share, respectively, for the nine months ended April 30, 2026.
(3)Includes time-based vesting for PSUs.
Schedule of Assumptions Used and Resulting Grant-date Fair Values The following table summarizes the assumptions used and the resulting grant-date fair value of our PSUs subject to market conditions granted during the nine months ended April 30, 2026 and 2025:
Nine Months Ended April 30,
20262025
Volatility
36.6% - 42.6%
43.5% - 47.6%
Expected term (in years)
1.0 - 3.0
1.0 - 2.9
Dividend yield0.0%0.0%
Risk-free interest rate
3.6% - 3.9%
3.7% - 4.5%
Grant-date fair value per share
$226.06 - $261.62
$264.51 - $305.83
Schedule of PSO Activity
The following table summarizes the PSO activity under our stock plans during the nine months ended April 30, 2026 (in millions, except per share amounts):
Number of Shares
Weighted-Average Exercise Price Per Share
Weighted-Average Remaining Contractual Term (Years)
Aggregate Intrinsic Value
Balance—July 31, 20251 $32.76 0.5$197 
Exercised(1)$32.76 
Balance—April 30, 2026— $— 0.0$— 
Exercisable—April 30, 2026— $— 0.0$— 
Schedule of Allocation of Share-based Compensation Expense
The following table summarizes share-based compensation included in costs and expenses (in millions):
Three Months Ended April 30,Nine Months Ended April 30,
2026202520262025
Cost of product revenue $2 $1 $4 $4 
Cost of subscription and support revenue 50 32 114 95 
Research and development206 134 477 411 
Sales and marketing188 92 388 258 
General and administrative238 67 372 173 
Total share-based compensation$684 $326 $1,355 $941